| Sustaining competitive advantage within the | | | | - LatvianLithuania - LithuanianMalta |
| medical device industry involves a global | | | | - English & MaltesePoland - |
| product strategy that recognizes the European | | | | PolishRomania - RomanianSlovakia - |
| market's substantial global market share. | | | | SlovakSlovenia - SlovenianTurkey |
| Estimated at 30% of the global medical device | | | | - TurkishEU Member State Official Languages |
| market, the European community poses | | | | |
| increasing regulatory challenges for medical | | | | Depending on the extent of the product's |
| device manufacturers. Regulations controlling | | | | presence in the European Union, there are |
| the manufacturing, marketing and usage of | | | | currently up to 12 languages required for the |
| medical devices in the EU are forcing | | | | labeling, IFUs, documentation, and marketing |
| manufacturers to incorporate language | | | | materials in accordance with the IVDD and MDD |
| translation and localization into global | | | | necessary for CE mark as displayed in TABLE I |
| development strategies as individual Member | | | | .As the EU continues to grow and the trading |
| States demand product information in the | | | | barriers dissolve, prospective Member States |
| language of the local user.An exigent | | | | are actively transitioning regulations to |
| regulatory hurdle facing the medical device | | | | meet the CE mark criteria, requiring new |
| industry is the European Union's IVDD 98/79 | | | | languages. A midday regulatory shadow to the |
| EC directive which went into effect December | | | | EU, European Free Trade Association (EFTA) |
| 7, 2003. Formulated five years ago, the IVDD | | | | countries of Iceland, Liechtenstein and |
| 98/79/EC dictates that as of the December | | | | Norway are aggressively enforcing the CE |
| date, all new in vitro medical devices must | | | | mark, shown in TABLE II . Although not a |
| bear CE Marks or face refusal into the | | | | member of the EFTA, Switzerland is also |
| European market or regulatory, criminal or | | | | enforcing medical device CE mark.In addition |
| product/civil liability.What is the guiding | | | | to the EFTA, 13 more countries have applied |
| principle behind the new directive?The IVDD | | | | for membership in the European Union. |
| Directive virtually eliminates the costly | | | | Performing a parallel migration to the |
| regulations imposed by individual member | | | | European Union's regulatory requirements, |
| states. Manufacturers who comply with the | | | | several of these future Member States are |
| Directive will be able to apply the CE mark | | | | actively adopting the CE Mark to ensure goods |
| to their products and market them freely | | | | can freely move throughout the European |
| within member states of the EU. | | | | Union, including Poland, Romania, Slovakia, |
| | | | and Turkey, seeTABLE III . |
| The IVDD (In Vitro Diagnostic Devices | | | | |
| Directive) is one of three associated | | | | Global Harmonization and International |
| directives issued by the European Union, | | | | Quality Standards |
| which together cover all forms of medical | | | | |
| equipment with the intent to ensure that only | | | | In 1998, the United States and the European |
| safe and effective products are sold in the | | | | Union introduced the New Transatlantic |
| European market. The directives clearly | | | | Agreement (NTA) to improve economic |
| outline regulations regarding manufacturing, | | | | cooperation between the two economic powers. |
| importing, and marketing of such devices. The | | | | In this landmark accord resides the Mutual |
| IVDD specifically involves in vitro ( in an | | | | Recognition Agreement (MRA) that acknowledges |
| artificial environment outside the living | | | | the regulatory standards of the respective |
| organism ) medical devices that examine human | | | | economic bodies-an area of transition that |
| fluids or tissue samples to identify, | | | | affects the medical device industry. The |
| diagnose, and monitor medical conditions. The | | | | European Union medical device directives |
| IVDD 98/79/EC brings in vitro devices in line | | | | refer to ISO 9001 as the series of quality |
| with other medical devices already regulated | | | | management standards and the US refers to |
| by the EU, the MDD (Medical Devices | | | | FDA's Quality System Requirements and all |
| Directive) and the AIMDD (Active Implantable | | | | corresponding good manufacturing (GMP) |
| Medical Devices Directive).The IVDD and it | | | | practices regulations. Benefiting medical and |
| sibling directives apply progressive | | | | pharmaceutical companies, both quality |
| regulatory requirements to medical devices | | | | systems have made considerable efforts to |
| and their accessories depending on the | | | | synchronize their requirements further |
| classified risk they present to the user, | | | | increasing the common ground between quality |
| defined in the directive as Class I through | | | | systems in North America and Europe.ISO |
| III. Unless the classified product is a | | | | (International Organization for |
| low-risk Class I device that does not contain | | | | Standardization) |
| any sterile packaging or a measuring | | | | |
| function, manufacturers require a third-party | | | | Adding to the pressure the current ISO |
| Notified Body to independently certify the | | | | 9000:1994 standard is transitioning to a new |
| device's compliance to the Directive's | | | | ISO: 9000:2000 series effective December 14th |
| Essential Requirements (a.k.a. Annex I)-good | | | | of this year. However, as of May 15, 2003, |
| faith is not enough. Additionally, in a new | | | | only 19.5% of the total ISO registered North |
| twist within the Directive, the authorized | | | | American companies had completed their |
| representative shown on the device label for | | | | registration process. This is essential in |
| Class I devices manufactured outside the EU | | | | the entire chain of requirements. The new |
| may be required to produce the technical | | | | standard is a consolidation of ISO 9001 and |
| file, including copies of all translated | | | | 9002, and has more of a customer satisfaction |
| materials. Any incorrect labeling or | | | | and continuous improvement focus not present |
| instructions for use may lead to regulatory | | | | in previous versions.GMP (Good Manufacturing |
| criminal or product/civil liability in the | | | | Practices) |
| EU.Any medical device manufacturer wishing to | | | | |
| market its products in the European Union is | | | | In December 1978, the FDA Good Manufacturing |
| fully responsible for complying with the | | | | Practices (GMP) Regulation became effective, |
| corresponding safety and administrative | | | | establishing Quality System Requirements for |
| Essential Requirements and must display the | | | | products regulated under the FDA, including |
| CE mark of conformity as stated in Article 16 | | | | medical devices. In 1990, the Safe Medical |
| of the IVDD 98/79/EC . If that's not a red | | | | Devices Act (SMDA) expanded the GMP to |
| flag, consider the next regulatory deadline | | | | include design, manufacturing, packaging, |
| facing in vitro device manufacturers: By | | | | labeling, storage, installation and servicing |
| December 7, 2005, the European Union will not | | | | of all finished medical devices.Exporting |
| only require a CE mark to legally market a | | | | American Medical Devices |
| product, but will require a CE mark to | | | | |
| legally put a medical device into service-a | | | | Any medical device in the US market may not |
| requirement much more critical to the revenue | | | | be legally exported anywhere in the world |
| of manufacturers and healthcare!CE Mark: A | | | | without prior FDA notification or approval; |
| passport to the European Union | | | | however, for a device to be legally |
| | | | distributed in the US, the FDA requires: |
| An abbreviation of a French phase | | | | |
| "Conformite Europeene," the CE mark indicates | | | | Registration of both the medical device and |
| that the medical device manufacturer has | | | | manufacturing site- Authorization for |
| conformed to all the obligations set forth by | | | | commercial distribution through either a |
| the Directive 98/79/EC of the European | | | | 510(k) pre-market notification or a |
| Parliament. Affixing this multinational | | | | Pre-market Approval (PMA) application |
| standardized mark to a product will allow any | | | | depending upon the classification of the |
| global manufacturer a "passport" to freely | | | | device- Compliance with FDA labeling |
| distribute their products within the European | | | | requirements- Manufacturing compliance with |
| Union without additional quality testing or | | | | the FDA's GoodManufacturing Practices |
| approvals. Reflective of the 1946 Treaty of | | | | (GMP)While the FDA does not place any |
| Rome, the CE mark is a conformity tool that | | | | restrictions on the export of these devices, |
| is intended to further promote the | | | | certain countries require an Export |
| establishment of a single market where the | | | | Certificate that the manufacturer and its |
| free movement of goods, persons, services and | | | | devices are indeed in compliance with FDA |
| capital are ensured. Fundamentally, the CE | | | | regulations. Medical devices that do not have |
| mark and the medical device directives remove | | | | a 510(k), PMA, or are solely manufactured for |
| many regulatory hurdles while providing | | | | export may by approved for exportation by the |
| stronger regulations for smaller countries; | | | | FDA through Section 801(e)(1) of the FFDCA; |
| however, it also creates critical language | | | | however, the manufacturer may experience |
| compliance issues that may prove to be costly | | | | regulatory difficulties depending on the |
| for manufacturers. Regardless of the intended | | | | individual country's requirements of an FDA |
| global harmonization, participating countries | | | | Export Certificate, which, as stated above, |
| are preserving their national cultures and | | | | require a 510 (k) or a PMA.Sorting through |
| languages by requiring product information in | | | | the regulations to achieve global product |
| their own local languages.IVDD, MDD & | | | | delivery |
| AIMD...more languages! | | | | |
| | | | The question facing medical device |
| Depending on device classification, to | | | | manufacturers in the current global market is |
| legally display the CE mark, the IVDD, MDD, | | | | how to meet all language requirements in the |
| and AIMD all mandate that manufacturers | | | | most cost-effective, regulatory compliant |
| provide all labeling, information for usage, | | | | manner. Managing regulations and translations |
| documentation, and marketing materials in the | | | | are among the most critical aspects of |
| official language(s) of the end-user's Member | | | | developing and marketing products for the |
| State, taking into account the training and | | | | life sciences industries. Any mistake, no |
| knowledge of the potential users as stated in | | | | matter how minor, can delay product |
| Article 4, Paragraph 4, IVDD 98/79/EC | | | | approvals, launches, or cause widespread |
| .Documentation Translation Requirements - | | | | public relations disasters. Therefore, |
| Conformity Assessment Procedures | | | | developing translation and localization |
| | | | processes has become a competitive advantage |
| Manufacturers are required to translate the | | | | for global manufacturers of medical |
| documentation relating to the production, | | | | devices.Working closely with a translation |
| testing and quality processes in the official | | | | and localization vendor who specializes in |
| language(s) of the Member State in which the | | | | medical language services is an important |
| procedures are carried out as stated in | | | | step in conquering the ever-changing |
| Article 9, Paragraph 11 of the IVDD 98/79/EC. | | | | international regulatory process. The choice |
| Depending on device classification, these | | | | of the translation provider is extremely |
| documents must include a number of required | | | | important to ensure that translations are |
| disclosures dependent on the product | | | | accurate, consistent and technically correct, |
| classification. | | | | as well as harmonious with the manufacturers' |
| | | | processes.Medical language service providers |
| Depending on marketing and distribution | | | | should-at the very least-provide documented |
| objectives, some products may require up to | | | | processes that involve native-speaking |
| 12 languages, creating complicated | | | | linguists that have expertise in both medical |
| multilingual product labeling and IFU | | | | translation and the medical industry. To |
| challenges. There can be over 20 information | | | | deliver consistency, quality and reduced |
| pieces required for each product label of | | | | costs, the language service provider should |
| IFU, depending on the classification as | | | | also implement terminology management tools |
| detailed in Annex I, Part B, Section 8 of the | | | | and computer-assisted translation solutions |
| Directive.Table I | | | | in concert with the team of human |
| | | | translators.Conclusion |
| Official Language(s) of EU Member | | | | |
| StatesMember State Official | | | | Complex and ever-changing international |
| language(s)Austria - GermanBelgium - | | | | regulations controlling the marketing and |
| Dutch, French & GermanDenmark - | | | | usage of medical devices are forcing |
| DanishFinland - FinnishFrance - | | | | manufacturers to incorporate language |
| FrenchGermany - GermanGreece - | | | | translation and localization into global |
| GreekIreland - EnglishItaly - | | | | development strategies. The European Union |
| ItalianLuxembourg - French, German, | | | | members currently require that all product |
| LuxembourgishNetherlands - DutchPortugal | | | | information be in the official language of |
| - PortugueseSpain - | | | | the local users and the diversity of this |
| SpanishSweden - SwedishUnited | | | | economic area is only growing to include more |
| Kingdom - EnglishTable II | | | | regulations and official languages. A |
| | | | simultaneous global release of medical |
| Official Language(s) of EFTA Member States | | | | devices involving up to 12 languages in |
| | | | Europe alone makes this issue as critical as |
| Member State Official language(s)Iceland - | | | | the intended purpose of the medical device. |
| IcelandicLiechtenstein - GermanNorway | | | | |
| - NorwegianSwitzerland - German, | | | | Medical device manufacturers can |
| French & Italian( Switzerland is not a EFTA | | | | cost-effectively market their products |
| member but requires translation)Table III | | | | globally while satisfying international |
| | | | regulatory requirements by partnering with |
| Official Language(s) of Member States | | | | Net-Translators a qualified language service |
| Applying For EU Membership | | | | provider in the very early stages of product |
| | | | development. The right language partner can |
| Member State Official language(s) Bulgaria | | | | turn what may now appear as a chaos of |
| - BulgarianCyprus - GreekCzech | | | | regulatory requirements into a successful |
| Republic - CzechEstonia - | | | | international product release. |
| EstonianHungary - HungarianLatvia | | | | |